A citation-based method for searching scientific literature

Marta Elżbieta Kasprzyk, Weronika Sura, Agnieszka Dzikiewicz-Krawczyk. Cancers (Basel) 2021
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Histone H3K27ac separates active from poised enhancers and predicts developmental state.
Menno P Creyghton, Albert W Cheng, G Grant Welstead, Tristan Kooistra, Bryce W Carey, Eveline J Steine, Jacob Hanna, Michael A Lodato, Garrett M Frampton, Phillip A Sharp,[...]. Proc Natl Acad Sci U S A 2010
33

Erroneous class switching and false VDJ recombination: molecular dissection of t(8;14)/MYC-IGH translocations in Burkitt-type lymphoblastic leukemia/B-cell lymphoma.
Thomas Burmeister, Mara Molkentin, Stefan Schwartz, Nicola Gökbuget, Dieter Hoelzer, Eckhard Thiel, Richard Reinhardt. Mol Oncol 2013
17
33

B Cell Development and Maturation.
Ying Wang, Jun Liu, Peter D Burrows, Ji-Yang Wang. Adv Exp Med Biol 2020
45
33

Targeting the Bcl-2 Family in B Cell Lymphoma.
Clare M Adams, Sean Clark-Garvey, Pierluigi Porcu, Christine M Eischen. Front Oncol 2019
73
33


Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives.
Shirin Hafezi, Mohamed Rahmani. Cancers (Basel) 2021
31
33

The IgH locus 3' regulatory region: pulling the strings from behind.
Eric Pinaud, Marie Marquet, Rémi Fiancette, Sophie Péron, Christelle Vincent-Fabert, Yves Denizot, Michel Cogné. Adv Immunol 2011
87
33

Diversity and Emerging Roles of Enhancer RNA in Regulation of Gene Expression and Cell Fate.
Preston R Arnold, Andrew D Wells, Xian C Li. Front Cell Dev Biol 2020
89
33



Emerging Roles of SIRT1 in Cancer Drug Resistance.
Zhiqiang Wang, Wenyong Chen. Genes Cancer 2013
53
33

Oncogenes as molecular targets in lymphoma.
Ali Hachem, Ronald B Gartenhaus. Blood 2005
20
33

Eμ and 3'RR transcriptional enhancers of the IgH locus cooperate to promote c-myc-induced mature B-cell lymphomas.
Nour Ghazzaui, Hussein Issaoui, Mélissa Ferrad, Claire Carrion, Jeanne Cook-Moreau, Yves Denizot, François Boyer. Blood Adv 2020
8
33



Enhancer RNAs are an important regulatory layer of the epigenome.
Vittorio Sartorelli, Shannon M Lauberth. Nat Struct Mol Biol 2020
103
33

Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes.
Birgit Heltweg, Tonibelle Gatbonton, Aaron D Schuler, Jeff Posakony, Hongzhe Li, Sondra Goehle, Ramya Kollipara, Ronald A Depinho, Yansong Gu, Julian A Simon,[...]. Cancer Res 2006
376
33


Advances in histone demethylase KDM4 as cancer therapeutic targets.
Dong Hoon Lee, Go Woon Kim, Yu Hyun Jeon, Jung Yoo, Sang Wu Lee, So Hee Kwon. FASEB J 2020
46
33

Modification of enhancer chromatin: what, how, and why?
Eliezer Calo, Joanna Wysocka. Mol Cell 2013
841
33

The IgH 3' regulatory region and c-myc-induced B-cell lymphomagenesis.
Nour Ghazzaui, Alexis Saintamand, Hussein Issaoui, Christelle Vincent-Fabert, Yves Denizot. Oncotarget 2017
11
33

Strong KDM4B and KDM4D Expression Associates with Radioresistance and Aggressive Phenotype in Classical Hodgkin Lymphoma.
Hamid Bur, Kirsi-Maria Haapasaari, Taina Turpeenniemi-Hujanen, Outi Kuittinen, Päivi Auvinen, Katja Marin, Ylermi Soini, Peeter Karihtala. Anticancer Res 2016
10
33


The Roles of SIRT1 in Cancer.
Zhenghong Lin, Deyu Fang. Genes Cancer 2013
127
33

KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells.
William L Berry, Ralf Janknecht. Cancer Res 2013
275
33

KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas.
James Heward, Lola Konali, Annalisa D'Avola, Karina Close, Alison Yeomans, Martin Philpott, James Dunford, Tahrima Rahim, Ahad F Al Seraihi, Jun Wang,[...]. Blood 2021
15
33

DNA damage response and apoptosis.
Dragos Plesca, Suparna Mazumder, Alexandru Almasan. Methods Enzymol 2008
86
33

Clinical Impact of t(14;18) in Diffuse Large B-cell Lymphoma.
Hong-Wei Zhang, Niu-Liang Cheng, Zhen-Wen Chen, Jin-Fen Wang, Su-Hong Li, Wei Bai. Chin J Cancer Res 2011
5
33

Role of SIRT1 in hematologic malignancies.
Fei-Teng Huang, Jie Sun, Lei Zhang, Xin He, Ying-Hui Zhu, Hao-Jie Dong, Han-Ying Wang, Lei Zhu, Jing-Ying Zou, Jin-Wen Huang,[...]. J Zhejiang Univ Sci B 2019
7
33

Mouse Models of c-myc Deregulation Driven by IgH Locus Enhancers as Models of B-Cell Lymphomagenesis.
Melissa Ferrad, Nour Ghazzaui, Hussein Issaoui, Jeanne Cook-Moreau, Yves Denizot. Front Immunol 2020
9
33



MYC phosphorylation at novel regulatory regions suppresses transforming activity.
Amanda R Wasylishen, Michelle Chan-Seng-Yue, Christina Bros, Dharmendra Dingar, William B Tu, Manpreet Kalkat, Pak-Kei Chan, Peter J Mullen, Ling Huang, Natalie Meyer,[...]. Cancer Res 2013
24
33




Spatial proximity of translocation-prone gene loci in human lymphomas.
Jeffrey J Roix, Philip G McQueen, Peter J Munson, Luis A Parada, Tom Misteli. Nat Genet 2003
315
33

Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma.
A Gerbitz, J Mautner, C Geltinger, K Hörtnagel, B Christoph, H Asenbauer, G Klobeck, A Polack, G W Bornkamm. Oncogene 1999
43
33

Expression of P0- and P3-RNA from the normal and translocated c-myc allele in Burkitt's lymphoma cells.
D Eick, A Polack, E Kofler, G M Lenoir, A B Rickinson, G W Bornkamm. Oncogene 1990
34
33

Alternative splicing and cell survival: from tissue homeostasis to disease.
Maria Paola Paronetto, Ilaria Passacantilli, Claudio Sette. Cell Death Differ 2016
104
33

DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
Alex I Zaika, Neda Slade, Susan H Erster, Christine Sansome, Troy W Joseph, Michael Pearl, Eva Chalas, Ute M Moll. J Exp Med 2002
295
33


Burkitt lymphoma in the mouse.
A L Kovalchuk, C F Qi, T A Torrey, L Taddesse-Heath, L Feigenbaum, S S Park, A Gerbitz, G Klobeck, K Hoertnagel, A Polack,[...]. J Exp Med 2000
147
33

Comprehensive Epstein-Barr Virus Transcriptome by RNA-Sequencing in Angioimmunoblastic T Cell Lymphoma (AITL) and Other Lymphomas.
Nader Bayda, Valentin Tilloy, Alain Chaunavel, Racha Bahri, Mohamad Adnan Halabi, Jean Feuillard, Arnaud Jaccard, Sylvie Ranger-Rogez. Cancers (Basel) 2021
7
33

Selective targeting of MYC mRNA by stabilized antisense oligonucleotides.
Taylor Gill, Haichuan Wang, Raj Bandaru, Matthew Lawlor, Chenyue Lu, Linda T Nieman, Junyan Tao, Yixian Zhang, Daniel G Anderson, David T Ting,[...]. Oncogene 2021
2
50

The c-myc promoter: still MysterY and challenge.
Inken Wierstra, Jürgen Alves. Adv Cancer Res 2008
148
33


Analysis of polyadenylation site usage of the c-myc oncogene.
I A Laird-Offringa, P Elfferich, H J Knaken, J de Ruiter, A J van der Eb. Nucleic Acids Res 1989
28
33

The many roles of c-Myc in apoptosis.
E B Thompson. Annu Rev Physiol 1998
229
33

Complete motif analysis of sequence requirements for translation initiation at non-AUG start codons.
Alexander J Diaz de Arce, William L Noderer, Clifford L Wang. Nucleic Acids Res 2018
33
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.